19 related articles for article (PubMed ID: 1490807)
1. Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
Wang YX; Li JL; Wang XD; Zhang Y; Wang CX; Huang M
Acta Pharmacol Sin; 2015 Jul; 36(7):855-62. PubMed ID: 25891084
[TBL] [Abstract][Full Text] [Related]
2. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
Wang Y; Wang C; Li J; Wang X; Zhu G; Chen X; Bi H; Huang M
Eur J Clin Pharmacol; 2009 Mar; 65(3):239-47. PubMed ID: 18936931
[TBL] [Abstract][Full Text] [Related]
3. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.
Tsunoda SM; Aweeka FT
Clin Pharmacokinet; 1996 Feb; 30(2):107-40. PubMed ID: 8906895
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a monoclonal antibody fluorescent polarization immunoassay with monoclonal antibody radioimmunoassay for cyclosporin determination in whole blood.
Alvarez JS; Sacristan JA; Alsar MJ
Ther Drug Monit; 1992 Feb; 14(1):78-80. PubMed ID: 1546394
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring of cyclosporin A concentration in whole blood with fluorescence polarization immunoassay after bone marrow transplantation].
Murayama T; Matsushita K; Takahashi T; Matozaki S; Nakagawa T; Isobe T
Rinsho Ketsueki; 1992 Apr; 33(4):413-7. PubMed ID: 1602602
[TBL] [Abstract][Full Text] [Related]
6. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients.
McBride JH; Kim SS; Rodgerson DO; Reyes AF; Ota MK
Clin Chem; 1992 Nov; 38(11):2300-6. PubMed ID: 1424128
[TBL] [Abstract][Full Text] [Related]
7. Is the monoclonal fluorescence polarization immunoassay for cyclosporine specific? Comparison with specific radioimmunoassay.
Armijo JA; Navarro FA; Angeles de Cos M
Ther Drug Monit; 1992 Aug; 14(4):333-8. PubMed ID: 1519309
[TBL] [Abstract][Full Text] [Related]
8. Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassay.
Morris RG; Saccoia NC; Ryall RG; Peacock MK; Sallustio BC
Ther Drug Monit; 1992 Jun; 14(3):226-33. PubMed ID: 1412609
[TBL] [Abstract][Full Text] [Related]
9. Measurement of cyclosporin A in whole blood by RIA, EMIT and FPIA: a comparative study.
Wacke R; Drewelow B; Hehl EM; Riethling AK
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):502-3. PubMed ID: 1490807
[No Abstract] [Full Text] [Related]
10. A new look at the limits of detection (LD), quantification (LQ) and power of definition (PD).
Gautschi K; Keller B; Keller H; Pei P; Vonderschmitt DJ
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):433-40. PubMed ID: 8399783
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
